Opus Genetics (IRD) Operating Expenses (2010 - 2026)
Opus Genetics (IRD) posted quarterly Operating Expenses of $16.5 million for Q1 2026, up 15.54% year-over-year from $14.3 million in Q1 2025, and up 7.85% quarter-over-quarter from $15.3 million in Q4 2025.
Opus Genetics (IRD) Operating Expenses (2010 - 2026) Analysis & Trends
Opus Genetics (IRD) has reported Operating Expenses for 17 consecutive years, with $16.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Expenses rose 15.54% year-over-year to $16.5 million; the TTM figure through Mar 2026 stood at $55.0 million (down 29.42% YoY), while the FY2025 annual figure was $52.8 million, down 27.74% from the prior year.
- Operating Expenses improved to $16.5 million in Q1 2026 per IRD's latest filing, from $15.3 million in the prior quarter.
- Across five years, Operating Expenses topped out at $42.3 million in Q4 2024 and bottomed at $4.5 million in Q3 2022.
- Historically, Operating Expenses has averaged $11.4 million across 5 years, with a median of $9.4 million in 2024.
- Annual changes were most pronounced in 2024 — Operating Expenses soared 494.54% — and 2025, when it slumped 63.81%.
- Opus Genetics' Operating Expenses stood at $5.6 million in 2022, then gained by 26.24% to $7.1 million in 2023, then jumped by 494.54% to $42.3 million in 2024, then sank by 63.81% to $15.3 million in 2025, then increased by 7.85% to $16.5 million in 2026.
- Business Quant data shows IRD's Operating Expenses at $16.5 million in Q1 2026, $15.3 million in Q4 2025, and $11.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Opus Genetics | 298.36 Mn | 209.55 Mn | - | 17.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 17.24 Mn |
| Mar 31, 2026 | 16.52 Mn |
| Dec 31, 2025 | 15.32 Mn |
| Sep 30, 2025 | 11.39 Mn |
| Jun 30, 2025 | 11.79 Mn |
| Mar 31, 2025 | 14.30 Mn |
| Dec 31, 2024 | 42.33 Mn |
| Sep 30, 2024 | 11.88 Mn |
| Jun 30, 2024 | 9.44 Mn |
| Mar 31, 2024 | 9.42 Mn |
| Dec 31, 2023 | 7.12 Mn |
| Sep 30, 2023 | 5.55 Mn |
| Jun 30, 2023 | 9.06 Mn |
| Mar 31, 2023 | 7.88 Mn |
| Dec 31, 2022 | 5.64 Mn |
| Sep 30, 2022 | 4.54 Mn |
| Jun 30, 2022 | 4.94 Mn |
| Mar 31, 2022 | 6.51 Mn |
| Dec 31, 2021 | 6.15 Mn |
| Sep 30, 2021 | 4.72 Mn |